6.1 Diabetic Ketoacidosis (DKA) & Hypoglycemia in Pediatric Emergency Patients

Introduction to Pediatric Endocrine Emergencies

Pediatric endocrine and metabolic emergencies represent high-acuity clinical scenarios in the pediatric emergency department (ED). Children, particularly infants and young toddlers, have limited metabolic reserves, unique physiological responses to osmotic stress, and rapid disease progression. Among pediatric endocrine disorders, Diabetic Ketoacidosis (DKA) and acute severe hypoglycemia require immediate triage recognition, meticulous weight-based intervention, and continuous monitoring. A subtle mistake in fluid calculation or insulin administration can lead to catastrophic neurological complications such as cerebral edema or severe hypokalemia.

---

Pediatric Diabetic Ketoacidosis (DKA): Diagnostic Criteria & Severity

DKA is a life-threatening acute metabolic complication of Type 1 Diabetes Mellitus (T1DM), resulting from absolute or relative insulin deficiency coupled with counter-regulatory hormone excess (glucagon, catecholamines, cortisol, and growth hormone). In pediatric emergency patients, up to 30% to 50% of new-onset T1DM cases present initially in DKA.

Diagnostic Criteria

To establish a diagnosis of pediatric DKA, all three of the following criteria must be present:

1. Hyperglycemia: Blood glucose > 200 mg/dL (11.1 mmol/L).
2. Metabolic Acidosis: Venous pH < 7.30 OR serum bicarbonate < 15 mEq/L.
3. Ketonemia / Ketonuria: Serum beta-hydroxybutyrate ≥ 3.0 mmol/L or moderate-to-large urine ketones.

Severity Categorization

Severity categorization guides fluid resuscitation intensity and nursing monitoring protocols:

• Mild DKA: Venous pH 7.25 to 7.29; Serum bicarbonate 10 to 14 mEq/L.
• Moderate DKA: Venous pH 7.10 to 7.24; Serum bicarbonate 5 to 9 mEq/L.
• Severe DKA: Venous pH < 7.10; Serum bicarbonate < 5 mEq/L.

+-----------------------------------------------------------------------------------------+
|                              PEDIATRIC DKA DIAGNOSTIC TRIAD                             |
+----------------------------+-----------------------------+------------------------------+
|       HYPERGLYCEMIA        |      METABOLIC ACIDOSIS     |     KETONE ELEVATION         |
|   Blood Glucose > 200 mg/dL| Venous pH < 7.30 OR         | Serum Beta-hydroxybutyrate   |
|        (11.1 mmol/L)       | Bicarbonate < 15 mEq/L      |  ≥ 3.0 mmol/L / Ketonuria    |
+----------------------------+-----------------------------+------------------------------+

Clinical Presentation & Triage Assessment

Children presenting with DKA exhibit classic osmotic symptoms: polyuria, polydipsia, weight loss, and secondary nocturnal enuresis. As acidosis deepens, compensatory Kussmaul breathing (deep, rapid, hyperpneic respirations) develops to blow off carbon dioxide. Patients emit a characteristic fruity or acetone odor on their breath. Abdominal pain, nausea, and vomiting are common secondary to ileus and ketosis, often mimicking an acute surgical abdomen. Triage nurses must recognize signs of dehydration (sunken eyes, dry mucous membranes, delayed capillary refill, tachycardia) and altered mental status ranging from somnolence to coma.

---

Resuscitation & Safety Protocols: Fluid Resuscitation, Insulin, & Electrolytes

1. Fluid Resuscitation Protocol

The initial goal of fluid therapy in pediatric DKA is restoring intravascular volume and renal perfusion without causing rapid fluid shifts between extracellular and intracellular compartments.

• Initial Bolus: Administer 10 to 20 mL/kg of 0.9% Normal Saline (NS) over 60 minutes. If the patient is in frank hypovolemic shock, repeat 10–20 mL/kg boluses until hemodynamically stable.
• Maintenance & Deficit Fluid Calculation: Assume a 5% to 10% fluid deficit. Calculate total fluid requirement (maintenance + remaining deficit) and replace evenly over 48 hours. Avoid aggressive rehydration exceeding 1.5 to 2 times the normal maintenance rate to minimize cerebral edema risk.

2. Continuous Insulin Infusion Safety

• NO IV INSULIN BOLUS: An intravenous bolus of regular insulin is strictly contraindicated in pediatric DKA. An insulin bolus causes rapid intracellular shifts of potassium and glucose, triggering fatal hypokalemia, acute hypotension, and precipitous falls in serum osmolality that provoke cerebral edema.
• Infusion Rate: Initiate continuous Regular Insulin infusion at 0.05 to 0.1 units/kg/hour starting 1 to 2 hours after initiating fluid resuscitation.
• Two-Bag System: To maintain blood glucose between 150 and 250 mg/dL while continuing insulin to clear ketosis, nurses utilize two IV fluid bags with identical electrolyte concentrations:
  • Bag 1: 0.45% or 0.9% NS + electrolytes (0% Dextrose).
  • Bag 2: D10W in 0.45% or 0.9% NS + electrolytes (10% Dextrose).
  • The infusion rates of Bag 1 and Bag 2 are adjusted inversely based on hourly point-of-care (POC) glucose values, maintaining a smooth dextrose administration rate while keeping the insulin infusion constant.

3. Electrolyte Replacement Strategy

• Potassium: Total body potassium is severely depleted due to osmotic diuresis and urinary loss, despite initial serum potassium appearing normal or elevated (due to acidotic extracellular shifting). Add 20 to 40 mEq/L potassium (typically a 50:50 mixture of potassium chloride and potassium phosphate) to replacement fluids once urine output is documented and serum potassium is < 5.5 mEq/L. If potassium is < 3.5 mEq/L, delay insulin initiation until potassium is restored.
• Sodium Bicarbonate: Bicarbonate administration is not recommended in pediatric DKA. It worsens intracellular brain acidosis, induces paradoxical central nervous system hypoxia, and significantly increases cerebral edema risk.

---

Cerebral Edema: Risk Factors, Monitoring, & Emergency Management

Symptomatic cerebral edema occurs in approximately 0.5% to 1% of pediatric DKA episodes, but carries a high mortality rate (20% to 25%) and severe neurological morbidity.

Emergency Bedside Management Protocol

If cerebral edema is suspected, the pediatric emergency nurse must initiate immediate medical intervention prior to sending the patient for CT neuroimaging:

1. Position the patient with head of bed elevated to 30 degrees in midline position.
2. Reduce IV fluid administration rate by 30% to 50%.
3. Administer 3% Hypertonic Saline at 2 to 5 mL/kg IV over 10 to 15 minutes OR Mannitol at 0.5 to 1.0 g/kg IV over 20 minutes.
4. Maintain airway, administer high-flow oxygen, and prepare for endotracheal intubation if Glasgow Coma Scale (GCS) score drops below 8 (avoid hyperventilation unless active herniation occurs).

---

Pediatric Hypoglycemia Management by Age

Pediatric hypoglycemia is defined as a blood glucose level insufficient to support tissue metabolic demands. Due to high brain-to-body mass ratios, infants and young children are acutely vulnerable to hypoglycemic brain injury.

Diagnostic Thresholds

• Neonate (< 28 days): Blood glucose < 45 mg/dL (2.5 mmol/L).
• Infant / Child: Blood glucose < 60 mg/dL (3.3 mmol/L), or symptomatic at < 70 mg/dL.

Emergency Treatment Protocols by Age & Route

• Oral Glucose: If conscious and able to swallow safely, administer 15 g of fast-acting oral carbohydrates (150 mL juice or oral glucose gel).
• Intravenous Dextrose Resuscitation ("Rule of 50s"):
  • Neonates: D10W at 2 mL/kg IV (provides 200 mg/kg dextrose). Never use higher concentrations in neonates.
  • Infants & Children: D10W at 2 to 5 mL/kg IV OR D25W at 1 to 2 mL/kg IV (avoid D50W due to severe hyperosmolality and peripheral vein phlebitis).
  • Adolescents: D50W at 1 mL/kg IV (maximum dose 25 to 50 mL).
• Glucagon Administration (No IV Access):
  • Weight < 20 kg (or age < 5 years): 0.5 mg IM/SQ.
  • Weight ≥ 20 kg (or age ≥ 5 years): 1.0 mg IM/SQ.
• Following initial bolus resuscitation, initiate a continuous maintenance dextrose infusion (D5W or D10W) to maintain target blood glucose levels > 80–100 mg/dL.